Interestingly, CREBBP-mutated lymphoma B cells maintained this dependency toward EP300 enzymatic activity which identify a unique vulnerability that provide exciting opportunities of targeting single mutant CREBBP or EP300 GC-derived lymphomas. The gene discussed is EP300; the disease is lymphoma.